Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $783.85 | 52 | 99.1% |
| Education | $6.97 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $161.58 | 13 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.34 | 6 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $90.66 | 7 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $63.46 | 3 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $55.60 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $48.34 | 4 | $0 (2017) |
| Braemar Manufacturing, LLC | $34.32 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $33.04 | 2 | $0 (2017) |
| PFIZER INC. | $29.81 | 2 | $0 (2017) |
| Amgen Inc. | $26.81 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $20.05 | 1 | Preventice Services, LLC ($20.05) |
| 2017 | $770.77 | 52 | Janssen Pharmaceuticals, Inc ($161.58) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2019 | Preventice Services, LLC | — | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: Cardiovascular Monitors | ||||||
| 10/06/2017 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/06/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/27/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/23/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/05/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/02/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/31/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/26/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/23/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/19/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $10.66 | General |
| 05/17/2017 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/12/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: Cardiovascular | ||||||
| 05/10/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2017 | Braemar Manufacturing, LLC | Cardiac Monitoring Suite (Device) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: Cardiology | ||||||
| 05/08/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2017 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $10.58 | General |
| Category: Cardiovascular | ||||||
| 05/03/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 508 | 878 | $196,860 | $38,050 |
| 2022 | 14 | 526 | 967 | $259,975 | $51,244 |
| 2021 | 15 | 814 | 1,320 | $307,050 | $57,735 |
| 2020 | 12 | 865 | 1,151 | $281,285 | $52,872 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 236 | $60,180 | $13,270 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 108 | $40,500 | $9,363 | 23.1% |
| 93798 | Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | Office | 2023 | 74 | 370 | $44,400 | $3,837 | 8.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 38 | $13,490 | $3,783 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $14,220 | $2,612 | 18.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 21 | $7,875 | $1,965 | 25.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $7,050 | $1,678 | 23.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $3,250 | $891.41 | 27.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 19 | 19 | $2,375 | $386.82 | 16.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $3,520 | $263.13 | 7.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 225 | 338 | $126,750 | $27,155 | 21.4% |
| 93798 | Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | Office | 2022 | 56 | 332 | $39,840 | $3,635 | 9.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 41 | $14,555 | $3,557 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 37 | $9,435 | $2,384 | 25.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 22 | 26 | $9,750 | $2,328 | 23.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $12,245 | $2,127 | 17.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 33 | $8,250 | $2,083 | 25.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $7,535 | $1,778 | 23.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 18 | $6,300 | $1,568 | 24.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $6,110 | $1,536 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $6,435 | $1,367 | 21.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 15 | 15 | $3,750 | $917.04 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 39 | 47 | $7,520 | $548.31 | 7.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 12 | 12 | $1,500 | $261.36 | 17.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 258 | 380 | $142,500 | $29,447 | 20.7% |
About Dr. Ron Nudel, MD
Dr. Ron Nudel, MD is a Interventional Cardiology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356342158.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ron Nudel, MD has received a total of $790.82 in payments from pharmaceutical and medical device companies, with $20.05 received in 2019. These payments were reported across 53 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($783.85).
As a Medicare-enrolled provider, Nudel has provided services to 2,713 Medicare beneficiaries, totaling 4,316 services with total Medicare billing of $199,901. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location New Haven, CT
- Active Since 08/03/2005
- Last Updated 10/18/2017
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1356342158
Products in Payments
- XARELTO (Drug) $161.58
- ENTRESTO (Drug) $90.66
- PRADAXA (Drug) $84.02
- PRALUENT (Drug) $63.46
- BRILINTA (Drug) $59.05
- PRALUENT ALIROCUMAB INJECTION (Biological) $55.60
- Cardiac Monitoring Suite (Device) $34.32
- ADVAIR (Drug) $33.04
- Corlanor (Drug) $26.81
- ELIQUIS (Drug) $25.24
- JARDIANCE (Drug) $20.32
- BYSTOLIC (Drug) $19.50
- Savaysa (Drug) $19.13
- VIAGRA (Drug) $16.68
- Edarbi (Drug) $15.26
- CHANTIX (Drug) $13.13
- Livalo (Drug) $10.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in New Haven
Barbara Burtness, M.d, M.D
Interventional Cardiology — Payments: $394,493
Hari Deshpande, Md, MD
Interventional Cardiology — Payments: $65,472
Devika Kir, Md, MD
Interventional Cardiology — Payments: $9,009